Matinas BioPharma Holdings (MTNB) EBIT Margin (QoQ) (2015 - 2023)
Matinas BioPharma Holdings (MTNB) EBIT Margin (QoQ) (2015 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.99 Bn | 132.14 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.80 Bn | 78.80 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.38 Bn | 60.19 Bn | 1.37 Bn |
| 4 | Moderna | 60.70 Bn | 55.56 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.22 Bn | 37.12 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.67 Bn | 28.36 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.45 Bn | 10.06 Bn | 668.28 Mn |
| 8 | Insmed | 27.47 Bn | 26.31 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.21 Bn | 26.37 Bn | - |
| 10 | Matinas BioPharma Holdings | 1.22 Mn | 406,176.27 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 63,537.00 |
| Mar 31, 2023 | -97,408.00 |
| Dec 31, 2022 | -169.00 |
| Sep 30, 2022 | 4,356.00 |
| Mar 31, 2021 | -2.94 Mn |
| Dec 31, 2020 | 1.62 Mn |
| Jun 30, 2018 | 997,360.00 |
| Mar 31, 2018 | -345,302.00 |
| Dec 31, 2017 | -272,187.00 |
| Sep 30, 2017 | 126,488.00 |
| Jun 30, 2017 | 2.11 Mn |
| Sep 30, 2015 | -48,727.00 |
| Jun 30, 2015 | 133,741.00 |